Homoharringtonine contributes to imatinib sensitivity in chronic myeloid leukemia cell lines

被引：0
|
作者：
Huang, B. [1 ]
Gao, D. [1 ]
机构：
[1] Inner Mongolia Med Univ, Affiliated Hosp, Hohhot, Peoples R China
来源：
EUROPEAN JOURNAL OF IMMUNOLOGY | 2019年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P2388
引用
收藏
页码：38 / 39
页数：2
相关论文
共 50 条
  • [1] Homoharringtonine contributes to imatinib sensitivity by blocking the EphB4/RhoA pathway in chronic myeloid leukemia cell lines
    Bin-Tao Huang
    Qing-Chun Zeng
    Wei-Hong Zhao
    Yan Tan
    Medical Oncology, 2014, 31
  • [2] Homoharringtonine contributes to imatinib sensitivity by blocking the EphB4/RhoA pathway in chronic myeloid leukemia cell lines
    Huang, Bin-Tao
    Zeng, Qing-Chun
    Zhao, Wei-Hong
    Tan, Yan
    MEDICAL ONCOLOGY, 2014, 31 (02)
  • [3] Homoharringtonine Contributes to Imatinib Sensitivity by Blocking EphB4/RhoA Pathway in Ph plus Myeloid Leukemia
    Liu Xiaoli
    Huang, Bintao
    Du, Qingfeng
    Zhang, Jinfang
    Xu, Na
    Xu, Lulu
    Xiao, Xiaozhen
    Zhou, Xuan
    BLOOD, 2012, 120 (21)
  • [4] Homoharringtonine (HHT) with Imatinib in Chronic, Accelerated, and Blast Phase Chronic Myeloid Leukemia (CML)
    Maiti, Abhishek
    Kantarjian, Hagop M.
    Ferrajoli, Alessandra
    Estrov, Zeev
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Jabbour, Elias J.
    Ravandi, Farhad
    O'Brien, Susan M.
    Cortes, Jorge E.
    BLOOD, 2016, 128 (22)
  • [5] Homoharringtonine suppresses imatinib resistance via the Bcl-6/p53 pathway in chronic myeloid leukemia cell lines
    Wang, Qian
    Ding, Wei
    Ding, Yihan
    Ma, Jingjing
    Qian, Zhaoye
    Shao, Jingxian
    Li, Yufeng
    ONCOTARGET, 2017, 8 (23) : 37594 - 37604
  • [6] Phase II trial of homoharringtonine with imatinib in chronic, accelerated, and blast phase chronic myeloid leukemia
    Maiti, Abhishek
    Cortes, Jorge
    Ferrajoli, Alessandra
    Estrov, Zeev
    Borthakur, Gautam
    Garcia-Manero, Guillermo
    Jabbour, Elias
    Ravandi, Farhad
    O'Brien, Susan
    Kantarjian, Hagop
    LEUKEMIA & LYMPHOMA, 2017, 58 (09) : 2240 - 2242
  • [7] Synergistic Effects of Inecalcitol With Imatinib and Dasatinib on Chronic Myeloid Leukemia Cell Lines
    Angel, Samuel
    Cowles, Emma
    Costa, Jeams
    AL Ani, Raad
    Venkatachalam, Kallidaikurichi v
    ANTICANCER RESEARCH, 2024, 44 (12) : 5193 - 5197
  • [8] Hyaluronan oligomers sensitize chronic myeloid leukemia cell lines to the effect of Imatinib
    Laura Lompardia, Silvina
    Diaz, Mariangeles
    Laura Papademetrio, Daniela
    Mascaro, Marilina
    Pibuel, Matias
    Alvarez, Elida
    Elvira Hajos, Silvia
    GLYCOBIOLOGY, 2016, 26 (04) : 343 - 352
  • [9] Hyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines
    Silvina Lompardía
    Mariángeles Díaz
    Matías Pibuel
    Daniela Papademetrio
    Daniela Poodts
    Cintia Mihalez
    Élida Álvarez
    Silvia Hajos
    Scientific Reports, 9
  • [10] Hyaluronan abrogates imatinib-induced senescence in chronic myeloid leukemia cell lines
    Lompardia, Silvina
    Diaz, Mariangeles
    Pibuel, Matias
    Papademetrio, Daniela
    Poodts, Daniela
    Mihalez, Cintia
    Alvarez, Elida
    Hajos, Silvia
    SCIENTIFIC REPORTS, 2019, 9 (1)
12345